Kobe, Japan

Junichi Yasuoka

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Sumitomo Chemical Company, Limited. Active years: 2012-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junichi Yasuoka. Retrieved from https://idiyas.com/inventor/junichi-yasuoka-2fkifwth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Junichi Yasuoka: Innovator in Pharmaceutical Chemistry

Introduction

Junichi Yasuoka is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding 2 patents that focus on the production of optically active compounds.

Latest Patents

Yasuoka's latest patents include a method for producing optically active 1-amino-2-vinylcyclopropanecarboxylic acid ester. This compound serves as a synthetic intermediate for pharmaceuticals and is produced through a specific process outlined in his patent. Another significant patent is for a method of producing optically active 4-amino-3-substituted phenylbutanoic acid. This invention provides various methods for producing several related compounds and their salts.

Career Highlights

Yasuoka is associated with Sumitomo Chemical Company, Limited, where he has been able to apply his expertise in pharmaceutical chemistry. His work has contributed to advancements in the production of important pharmaceutical intermediates.

Collaborations

Yasuoka has collaborated with notable coworkers, including Tetsuya Ikemoto and Shoji Fukuyo, enhancing the innovative efforts within his field.

Conclusion

Junichi Yasuoka's contributions to pharmaceutical chemistry through his patents demonstrate his commitment to innovation and the advancement of medical science. His work continues to impact the development of essential pharmaceutical compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…